Business Insights
Diagnostic Technologies
Diseases
Point-of-Care Testing
Research & Development
Sign In
Policy & Regulation
Trends & Finance
Mergers & Acquisitions: Page 2
Steward offloads outreach laboratory services business
By
LabPulse.com staff writers
Quest Diagnostics has acquired select assets of outreach laboratory services in Pennsylvania and Ohio from Steward Health Care System, a large, private, and fully-integrated for-profit system based in Dallas.
January 9, 2024
Tome Biosciences acquires Replace Therapeutics in $65M deal
By
LabPulse.com staff writers
Less than a month after Tome Biosciences emerged with $213 million in funding, the gene editing company will acquire Replace Therapeutics for $65 million in upfront and near-term milestones, with a total deal value of up to $185 million.
January 5, 2024
Roche signs $350M deal to buy POC technology from LumiraDx
By
LabPulse.com staff writers
Roche has entered into a definitive agreement to purchase point-of care (POC) technologies from LumiraDx for $295 million, with an additional payment of up to $55 million to fund the POC diagnostics platform business until the transaction closes.
January 3, 2024
Bristol Myers Squibb to acquire RayzeBio for $4.1B
By
LabPulse.com staff writers
In its second multibillion-dollar acquisition announced within a week, Bristol Myers Squibb will acquire RayzeBio, which develops radiopharmaceutical cancer therapeutics, in an agreement worth approximately $4.1 billion.
December 27, 2023
Bristol Myers Squibb acquires Karuna for $14B
By
LabPulse.com staff writers
Bristol Myers Squibb has made an agreement to buy biotech firm Karuna Therapeutics for $14 billion, an acquisition that gives the firm a promising experimental treatment for schizophrenia.
December 22, 2023
Illumina to divest Grail, will not further appeal FTC order
By
LabPulse.com staff writers
Illumina has said in a statement that it will not pursue further appeals, and will sell Grail “consistent with the European Commission's divestiture order, with the goal of finalizing the terms by the end of the second quarter of 2024.”
December 18, 2023
AstraZeneca to buy Icosavax in agreement worth up to $1.1B
By
LabPulse.com staff writers
AstraZeneca has agreed to buy vaccine developer Icosavax in a deal worth up to $1.1 billion.
December 13, 2023
PerkinElmer acquires Covaris
By
LabPulse.com staff writers
PerkinElmer has signed an agreement to acquire life sciences firm Covaris, which will expand its life sciences portfolio and provide entrance into the high-growth diagnostics end market.
December 8, 2023
Imaware acquires Binx Health’s consumer-testing business
By
LabPulse.com staff writers
Molecular diagnostics and consumer testing company Imaware has acquired Binx Health’s at-home consumer testing business for an undisclosed sum.
December 6, 2023
Thermo Fisher to acquire proteomics firm Olink
By
LabPulse.com staff writers
Thermo Fisher has announced plans to acquire Uppsala, Sweden-based proteomics company Olink for approximately $3.1 billion. The amount includes net cash of approximately $143 million.
October 17, 2023
European Commission orders Illumina to sell Grail
By
LabPulse.com staff writers
Illumina has been ordered by the European Commission to sell Grail following the European Union antitrust regulatory body’s determination to prohibit the $8 billion acquisition of the company.
October 12, 2023
Abcam founder urges shareholders to reject $5.7B sale to Danaher
By
Matt Limb
A founder of leading U.K. life sciences company Abcam has urged shareholders to reject a 4.5 billion pound ($5.7 billion) takeover bid by science and technology firm Danaher Corporation.
October 4, 2023
Previous Page
Page 2 of 11
Next Page